<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/354480</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;354480</article-id><article-id pub-id-type="other" hwp:sub-type="slug">354480</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">354480</article-id><article-id pub-id-type="other" hwp:sub-type="tag">354480</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Molecular Biology" hwp:journal="biorxiv"><subject>Molecular Biology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">5′ Modifications Improve Potency and Efficacy of DNA Donors for Precision Genome Editing</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2 xref-corresp-1-3"><label>*</label>Corresponding Authors: Erik J. Sontheimer, Jonathan K. Watts and Craig C. Mello Mailing Address: RNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation Street, AS5-2049, Worcester, MA 01605, USA. Phone: 508-845-1602, <email hwp:id="email-1">Erik.Sontheimer@umassmed.edu</email>, <email hwp:id="email-2">Jonathan.Watts@umassmed.edu</email>, <email hwp:id="email-3">Craig.Mello@umassmed.edu</email>.</corresp><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2"><label>9</label><p hwp:id="p-1">These authors contributed equally</p></fn><fn id="n2" fn-type="equal" hwp:id="fn-2" hwp:rev-id="xref-fn-2-1 xref-fn-2-2"><label>10</label><p hwp:id="p-2">These authors contributed equally</p></fn><fn id="n3" fn-type="equal" hwp:id="fn-3" hwp:rev-id="xref-fn-3-1 xref-fn-3-2"><label>11</label><p hwp:id="p-3">These authors contributed equally</p></fn><fn id="n4" fn-type="present-address" hwp:id="fn-4"><p hwp:id="p-4">A.M: Inscripta Therapeutics, Pleasanton, CA; G.A.D: Vertex Pharmaceuticals, Boston, MA; P.M.K: Bristol Myer Squibb, Cambridge MA.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7502-3141</contrib-id><name name-style="western" hwp:sortable="Ghanta Krishna S"><surname>Ghanta</surname><given-names>Krishna S</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-7502-3141"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1584-2417</contrib-id><name name-style="western" hwp:sortable="Chen Zexiang"><surname>Chen</surname><given-names>Zexiang</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-1584-2417"/></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Mir Aamir"><surname>Mir</surname><given-names>Aamir</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-1" hwp:rel-id="fn-2">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Dokshin Gregoriy A"><surname>Dokshin</surname><given-names>Gregoriy A</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-2" hwp:rel-id="fn-2">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Krishnamurthy Pranathi M"><surname>Krishnamurthy</surname><given-names>Pranathi M</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Yoon Yeonsoo"><surname>Yoon</surname><given-names>Yeonsoo</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Gallant Judith"><surname>Gallant</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><xref ref-type="fn" rid="n3" hwp:id="xref-fn-3-1" hwp:rel-id="fn-3">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Xu Ping"><surname>Xu</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref><xref ref-type="fn" rid="n3" hwp:id="xref-fn-3-2" hwp:rel-id="fn-3">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Zhang Xiao-Ou"><surname>Zhang</surname><given-names>Xiao-Ou</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Ozturk Ahmet"><surname>Ozturk</surname><given-names>Ahmet</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-6" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Shin Masahiro"><surname>Shin</surname><given-names>Masahiro</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Idrizi Feston"><surname>Idrizi</surname><given-names>Feston</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Liu Pengpeng"><surname>Liu</surname><given-names>Pengpeng</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-3" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="Gneid Hassan"><surname>Gneid</surname><given-names>Hassan</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-7" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="Lawson Nathan D"><surname>Lawson</surname><given-names>Nathan D</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-4" hwp:rel-id="aff-5">5</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Rivera-Pérez Jaime A"><surname>Rivera-Pérez</surname><given-names>Jaime A</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-4" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-17"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0881-0310</contrib-id><name name-style="western" hwp:sortable="Sontheimer Erik J"><surname>Sontheimer</surname><given-names>Erik J</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-8" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-2" hwp:rel-id="aff-7">7</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-0881-0310"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-18"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5706-1734</contrib-id><name name-style="western" hwp:sortable="Watts Jonathan K"><surname>Watts</surname><given-names>Jonathan K</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-9" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-5706-1734"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-19"><name name-style="western" hwp:sortable="Mello Craig C"><surname>Mello</surname><given-names>Craig C</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-10" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-3" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-3" hwp:rel-id="corresp-1">*</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5 xref-aff-1-6 xref-aff-1-7 xref-aff-1-8 xref-aff-1-9 xref-aff-1-10"><label>1</label><institution hwp:id="institution-1">RNA Therapeutics Institute, University of Massachusetts Medical School</institution>, Worcester, MA 01605</aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-2">Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School</institution>, Worcester, Massachusetts 01605</aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3 xref-aff-3-4"><label>3</label><institution hwp:id="institution-3">Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School</institution>, Worcester, MA</aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1"><label>4</label><institution hwp:id="institution-4">Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School</institution>, Worcester, MA</aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2 xref-aff-5-3 xref-aff-5-4"><label>5</label><institution hwp:id="institution-5">Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School</institution>, Worcester, Massachusetts, <country>USA</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School</institution>, Worcester, MA, <country>USA</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1 xref-aff-7-2 xref-aff-7-3"><label>7</label><institution hwp:id="institution-7">Program in Molecular Medicine, University of Massachusetts Medical School</institution>, 368 Plantation Street, Worcester, MA, 01605 <country>United States</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">Howard Hughes Medical Institute, University of Massachusetts Medical School</institution>, Worcester, MA, <country>USA</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-06-22T14:27:10-07:00">
    <day>22</day><month>6</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-03-04T18:00:16-08:00">
    <day>4</day><month>3</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-06-22T14:34:01-07:00">
    <day>22</day><month>6</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-03-04T18:03:47-08:00">
    <day>4</day><month>3</month><year>2021</year>
  </pub-date><elocation-id>354480</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-06-22"><day>22</day><month>6</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2021-03-04"><day>04</day><month>3</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-03-04"><day>04</day><month>3</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-5">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="354480.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/354480v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="354480.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/354480v2/354480v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/354480v2/354480v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-6">Nuclease-directed genome editing is a powerful tool for investigating physiology and has great promise as a therapeutic approach to correct mutations that cause disease. In its most precise form, genome editing can use cellular homology-directed repair (HDR) pathways to insert information from an exogenously supplied DNA repair template (donor) directly into a targeted genomic location. Unfortunately, particularly for long insertions, toxicity and delivery considerations associated with repair template DNA can limit HDR efficacy. Here, we explore chemical modifications to both double-stranded and single-stranded DNA-repair templates. We describe 5′-terminal modifications, including in its simplest form the incorporation of triethylene glycol (TEG) moieties, that consistently increase the frequency of precision editing in the germlines of three animal models (<italic toggle="yes">Caenorhabditis elegans</italic>, zebrafish, mice) and in cultured human cells.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-2">Key Words</title><kwd hwp:id="kwd-1">CRISPR</kwd><kwd hwp:id="kwd-2">HDR</kwd><kwd hwp:id="kwd-3">Modified donors</kwd><kwd hwp:id="kwd-4">Chemical modifications</kwd></kwd-group><counts><page-count count="51"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-7">The authors (K.S.G, A.M, G.A.D, H.G, J.K.W, E.J.S and C.C.M) have a patent application pending related to the findings described. Craig C. Mello is a co-founder and Scientific Advisory Board member of CRISPR Therapeutics, and Erik J. Sontheimer is a co-founder and Scientific Advisory Board member of Intellia Therapeutics.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-4">Introduction</title><p hwp:id="p-8">Precision genome editing by HDR often requires cells to use exogenously supplied DNA templates (donors) to repair targeted double-strand breaks (DSBs). Maximizing precision genome editing, therefore, requires understanding both how cells respond to DSBs and to exogenous donors. These responses can be influenced by many variables, including cell-intrinsic factors (e.g., genetics, cell type, and cell cycle stage) and cell-extrinsic factors (e.g., donor length, strandedness, and chemistry) <sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>–<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref></sup>. Each of these variables can influence the relative efficiency of HDR compared to competing DSB repair pathways, such as non-homologous end joining (NHEJ) <sup><xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>–<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref></sup>.</p><p hwp:id="p-9">In many organisms and cell types, high HDR efficiencies are readily achieved using short single-stranded oligodeoxynucleotide (ssODN) donor templates that permit single base changes or short insertions or deletions. However, HDR is frequently less efficient when longer double-stranded DNA (dsDNA) templates are used as donors. It is not known why longer DNA donors yield lower rates of HDR. In many cell types, high concentrations of dsDNA cause cytotoxicity, limiting the number of long donor molecules that can be safely delivered into cells. In addition, due to their size, long donor molecules may not transit the nuclear envelope as efficiently, reducing the effective concentration at the site of repair, or requiring cell division to gain access to the target locus. Moreover, end-joining ligation reactions assemble linear dsDNA molecules into concatemers in eukaryotic cells <sup><xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>–<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref></sup>, further limiting the number of individual donor molecules and their ability to diffuse to their DSB target sites.</p><p hwp:id="p-10">In an effort to improve nuclear delivery and HDR efficacy, we incorporated 5′ modifications into the donor molecules, including a simple triethylene glycol (TEG) moiety, a 2′– <italic toggle="yes">O</italic>–methyl (2′OMe) RNA::TEG modification, and a peptide nucleic acid (PNA) comprising the SV40 nuclear localization signal (NLS) (see Methods). These 5′ modified donors increased the efficiency of templated repair by 2- to 5-fold in cultured mammalian cells as well as germline editing of <italic toggle="yes">Caenorhabditis elegans,</italic> zebrafish <italic toggle="yes">(Danio rerio)</italic> and mouse <italic toggle="yes">(Mus musculus)</italic>. The modified donors exhibited a striking reduction in DNA ligation reactions including reduced self-ligation into concatemers and reduced sequence-independent ligation into cellular DSBs, suggesting that the 5′ modifications reduce the availability of 5′ ends for competing NHEJ reactions.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-5">Results</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-6">End-modified DNA donors increase the efficiencies of HDR in mammalian cells</title><p hwp:id="p-11">To examine the effects of donor end modifications on HDR in cultured mammalian cells, we took advantage of a modified traffic light reporter (TLR) comprising a “broken” GFP coding region followed by a frameshifted mCherry coding region <sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>, <xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup>. Cas9 targets the “broken” GFP, which can only be made functional if precisely repaired by HDR, resulting in green fluorescence. If Cas9-mediated DSBs are imprecisely repaired by NHEJ, approximately one third of the imprecise repair events will restore the reading frame of mCherry, resulting in red fluorescence. Cas9 and single guide RNA (sgRNA) expression vectors and dsDNA donors with or without 5′ modifications were electroporated into HEK293T TLR cells (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1A</xref>)</bold>, followed by flow cytometry to determine the percentage of cells expressing either GFP or mCherry.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8 xref-fig-1-9 xref-fig-1-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-1"><p hwp:id="p-12">5′ end-modified donors promote HDR in Traffic-Light Reporter (TLR) cells. (A) Schematic showing the TLR assay to quantify HDR efficiencies using unmodified or end-modified dsDNA donors. Editing efficiencies plotted as percentage of (B) GFP+ (HDR) and (C) mCherry+ (NHEJ) HEK293T TLR cells at different amounts of unmodified, 2′OMe-RNA::TEG-modified dsDNA donors. Editing efficiencies plotted as percentage of (D) GFP+ (HDR) and (E) mCherry+ (NHEJ) HEK293T TLR cells at 1.2 pmol of dsDNA donors indicated. Percentage of GFP+ cells obtained with dsDNA donors modified with various lengths of ethylene glycol (F) and with modifications to only one end or both5′ ends of the donor. TS-target strand, NTS-non-target strand (G). Mean ± s.d for at least three independent replicates are plotted; two replicates for TEG-donor in panel G.</p></caption><graphic xlink:href="354480v2_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-13">We first examined the performance of dsDNA donors modified with 15-nucleotide (nt) 2′OMe-RNA fused to triethylene glycol (RNA::TEG). Strikingly, the frequency of HDR increased with the amount of RNA::TEG-modified donor to a maximal 52% GFP+ cells at 1.2 pmol of donor before falling off at higher amounts of donor (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1B</xref></bold>). By contrast, a maximum HDR frequency of only 25% GFP+ cells was observed at 1.6 pmol of unmodified donor. Notably, 0.4 pmol RNA::TEG-modified donor was as efficient as 1.6 pmol unmodified donor, suggesting that the modified donor is ∼4-fold more potent than the unmodified donor (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Figure 1B</xref></bold>). The increase in GFP+ cells was accompanied by a corresponding reduction in mCherry+ cells (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Figure 1C</xref></bold>).</p><p hwp:id="p-14">We reasoned that that the 2′O-Methyl RNA linker could be used to anneal PNA oligos attached to peptides that might enhance nuclear uptake. To test this idea, we produced complementary peptide-nucleic acid (PNA) oligos linked to a nuclear localization signal peptide or complementary PNA alone and tested these for HDR. Annealing these PNA oligos was well tolerated and did not diminish HDR, however neither did they enhance HDR (<bold><xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Figure S1A-D</xref></bold>). Thus, further study will be needed to determine if RNA-TEG adapters can be used to append peptides or other molecules (e.g. CAS9 RNP) that stimulate HDR.</p><p hwp:id="p-15">We next used the TLR assay to define features of the RNA::TEG moiety that promote maximal HDR. Nucleofection of 1.2 pmol donors modified with 2′OMe-RNA, TEG, or covalent RNA::TEG moieties all boosted HDR while reducing NHEJ events (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-6" hwp:rel-id="F1">E</xref></bold>). Increasing the length of the ethylene glycol moiety (3, 6, or 12 repeats) supported similar levels of HDR with or without the 2′OMe-RNA moiety (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Figure 1F</xref></bold>). Finally, donors with TEG modification at both 5′ ends yielded slightly better HDR efficiencies than donors with modification at only one of the two 5′ ends (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Figure 1G</xref></bold>). However, donors with RNA::TEG modification at both 5′ ends or at only one of the 5′ ends yielded similar HDR efficiencies (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-9" hwp:rel-id="F1">Figure 1G</xref></bold>).</p><p hwp:id="p-16">To explore the utility of TEG- and RNA::TEG-modified donors for repair at other genomic loci, we generated donors to integrate full-length <italic toggle="yes">eGFP</italic> at the endogenous <italic toggle="yes">TOMM20</italic>, <italic toggle="yes">GAPDH</italic>, and <italic toggle="yes">SEC61B</italic> loci (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2A</xref></bold>). We found that TEG or RNA::TEG donors consistently exhibited increased HDR levels in HEK293T cells as measured by the fraction of cells expressing eGFP at <italic toggle="yes">TOMM20</italic> (2-fold), at <italic toggle="yes">GAPDH</italic> (3-fold), and at SEC61B (5-fold) when compared to unmodified dsDNA donor (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2B-D</xref></bold>). RNA::TEG-modified donors also substantially increased HDR in two cell types that are less amenable to editing, increasing HDR at the <italic toggle="yes">TOMM20</italic> locus in human foreskin fibroblasts (HFF) cells (2.3-fold) and at the <italic toggle="yes">Gapdh</italic> locus in Chinese hamster ovary (CHO) cells (6-fold) (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2E-F</xref></bold>).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-2"><p hwp:id="p-17">End-modified donors promote HDR at endogenous loci in mammalian cell cultures. (A) schematic representation of the 5′ modified donor design for eGFP insertion and FACS sorting is shown. Efficacy of eGFP integration at (B) <italic toggle="yes">TOMM20</italic> and (C) <italic toggle="yes">GAPDH</italic> (D) Sec61B loci in HEK293T cells using unmodified, TEG or 2′OMe-RNA::TEG-modified donors are plotted as percentage of GFP+ cells. Efficacy of eGFP integration at the (E) <italic toggle="yes">TOMM20</italic> locus in HFF (747 bp knock-in with ∼1kb homology arms) and (F) <italic toggle="yes">Gapdh</italic> locus in CHO (1635 bp knock-in with ∼800 bp homology arms) cells using dsDNA (500 ng) donors with and without 2′OMe-RNA::TEG modifications at the 5′ ends. (G) Schematic representation of the dsDNA donor design used for quantification with deep sequencing is shown. (H) Illumina sequencing reads with precise knock-in are plotted for dsDNA donors with 90bp homology arms at EMX1 locus in HEK293T cells. Mean ± s.d for at least three independent replicates are plotted. P-values were calculated using one-way ANOVA and in all cases end-modified donors were compared to unmodified donor unless indicated otherwise (Tukey’s multiple comparisons test; ****P &lt; 0.0001; ***P &lt; 0.001; **P &lt; 0.01; *P&lt; 0.05; ns-not significant).</p></caption><graphic xlink:href="354480v2_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-18">Next, to quantify the nature of repair outcomes (precise and imprecise), we employed deep sequencing assays. To facilitate sequencing across the repair site, we replaced a 12-nt sequence with a 9-nt sequence at the <italic toggle="yes">EMX1</italic> locus in HEK293T. We compared HDR efficiencies in this assay using unmodified, TEG-modified, and RNA::TEG-modified dsDNA donors with 90-base pair (bp) homology arms (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2G</xref></bold>). At 1.2 pmol and 2.4 pmol, RNA::TEG modified donors yielded two fold more precise edits compared to the unmodified donors. When even higher doses (5pmol) were used, the gap in efficacy between unmodified and RNA::TEG modified donors narrowed to just 16% (89.5% vs 72.8%) precise reads (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figure 2H</xref></bold>). The <italic toggle="yes">EMX1</italic> donor with 90-bp homology arms also supported high levels of HDR in K562 cells across a broad dose range. Notably, low doses of donor supported higher levels of HDR in K562 cells than in HEK293T cells, suggesting that K562 cells are more susceptible to editing (<bold><xref ref-type="fig" rid="figs2" hwp:id="xref-fig-8-1" hwp:rel-id="F8">Figure S2</xref></bold>). In this assay, donors modified with TEG alone exhibited no benefit over unmodified donors (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Figure 2H</xref></bold> and <bold><xref ref-type="fig" rid="figs2" hwp:id="xref-fig-8-2" hwp:rel-id="F8">Figure S2</xref></bold>).</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-7">5′-modification increases potency of single-stranded DNA donors</title><p hwp:id="p-19">The experiments described thus far employed dsDNA donors; however, long single-stranded DNA (ssDNA) or short single-stranded oligo deoxynucleotide (ssODN) donors are also widely used in many HDR editing protocols. We therefore decided to explore how 5′ end modifications affect single stranded donors of different lengths. Using the TLR assay, we found that addition of RNA::TEG at the 5′ end of a long (800-nt) ssDNA donor significantly boosted HDR compared to the unmodified ssDNA donor. The frequency of HDR increased with the dose of ssDNA donor, reaching maximal HDR (22.5% GFP(+)cells) at 6 pmol to 8 pmol donor amounts (<bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3A</xref>, <xref ref-type="fig" rid="figs3" hwp:id="xref-fig-9-1" hwp:rel-id="F9">Figure S3A</xref></bold>). The RNA::TEG-modified donor was greater than 4-fold more potent than the unmodified donor reaching a threshold of 16% GFP(+) cells at a concentration of approximately 2 pmol whereas achieving the same threshold of 16% required 8 pmol of unmodified donor (<bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3A</xref>)</bold>.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3.</label><caption hwp:id="caption-3"><p hwp:id="p-20">End-modifications increase potency of ssODN donors (A) Editing efficacy plotted as percentage of GFP+ (precise) HEK293T TLR cells at different amounts of unmodified and 2′OMe-RNA::TEG-modified long ssDNA donors (800 nt). (B) Editing efficacy of GFP-to-BFP reporter conversion in K562 cells using different amounts of unmodified and 2′OMe-RNA::TEG-modified 66 nt ssODN donors plotted as percentage of BFP+ cells (HDR). (C). Editing efficacy of GFP-to-BFP conversion in K562 cells using 0.5 pmol of ssODN donors modified at the 5′ end alone, the 3′ end alone, or at both the 5′ and 3′ ends, with phosphorothioate (PS), TEG, 2′OMe-RNA, or 2′OMe-RNA::TEG, plotted as percentage of BFP+ cells (precise). Complete figure of panel C is shown, along with other modifications, in <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-1" hwp:rel-id="F10">Figure. S4</xref>. Mean ± s.d for at least three independent replicates are plotted. P-values were calculated using one-way ANOVA and in all cases end-modified donors were compared to unmodified donor unless indicated otherwise (Tukey’s multiple comparisons test; ****P &lt; 0.0001; ***P &lt; 0.001; **P &lt; 0.01; *P&lt; 0.05; ns-not significant).</p></caption><graphic xlink:href="354480v2_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-21">High yields of HDR in cultured mammalian cells have been achieved using short synthetic single-stranded oligo deoxynucleotide (ssODN) donors <sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup>. To test 5′-modified ssODNs for HDR efficacy, we used a sensitive GFP-to-BFP conversion assay in K562 cells. Precise editing converts a functional GFP sequence to blue fluorescent protein (BFP) sequence, producing cells that are GFP(-) and BFP(+). Imprecise editing produces cells that are both GFP(-) and BFP(-) <sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref></sup>. Using 66 nt long ssODN donors and titrating the amount over a range of 0.01 to 40 pmol, we found that RNA::TEG and unmodified donors produced similar maximal levels of HDR (47.5% to 52.8% BFP(+) cells). However, maximal HDR required 10-fold less RNA::TEG-modified ssODN than unmodified donors (<bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3B</xref></bold>). We also observed reduced levels of imprecise editing (GFP-negative and BFP-negative) as the frequency of HDR increased (<bold><xref ref-type="fig" rid="figs3" hwp:id="xref-fig-9-2" hwp:rel-id="F9">Figure S3B</xref></bold>). For both donor types, the decline in editing at higher doses correlated with the appearance of dead cells (data not shown), suggesting that dose-limiting toxicity scales with increased HDR potency.</p><p hwp:id="p-22">The use of fully synthetic ssODN donors allowed us to explore additional modifications, including internal and 3′ modifications. Interestingly, 2′OMe-RNA, RNA::TEG, or TEG moieties at the 3′ terminus did not enhance HDR compared to unmodified ssODN, but they blocked the ability of 2′OMe-RNA, RNA::TEG, or TEG moieties at the 5′ end to enhance HDR (<bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Figure 3C</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-2" hwp:rel-id="F10">Figure S4</xref></bold>). By contrast, HDR was neither enhanced nor impeded by phosphorothioate (PS) linkages placed at 5′ or 3′ terminal linkages at the doses tested (<bold><xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-3" hwp:rel-id="F10">Figure S4</xref>)</bold>. Taken together these findings suggest that the mechanism of HDR improvement requires an available 3′-OH.</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-8">5′-modified donors promote precision germline editing in <italic toggle="yes">C. elegans</italic></title><p hwp:id="p-23">Efficient genome editing in <italic toggle="yes">C. elegans</italic> can be achieved by directly injecting mixtures of Cas9 ribonucleoprotein (RNP) complex and donor into the syncytial ovary<sup><xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>–<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref></sup>, producing dozens of independent precision editing events among the progeny of each injected animal <sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref></sup>. We designed unmodified, TEG-modified, and RNA::TEG-modified donors to insert <italic toggle="yes">gfp</italic> at the <italic toggle="yes">csr-1</italic> locus or to correct <italic toggle="yes">eft-3p::gfp</italic> reporter that contains partial sequence of <italic toggle="yes">gfp</italic> (see Methods; <bold><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4A</xref></bold>). To monitor injection quality, we co-injected a plasmid encoding the transformation marker <italic toggle="yes">rol-6(su1006)</italic>, which produces the Roller phenotype. The TEG- and RNA::TEG-modified donors produced about twice as many GFP(+) progeny per injected animal than did the unmodified donor (<bold><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Figure 4B</xref> and E,</bold> two representative broods per donor). Among the Roller cohort, which was previously shown to exhibit lower editing efficiency <sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref></sup>, end-modified donors increased the fraction of GFP(+) Roller progeny by several fold. For example, whereas the unmodified <italic toggle="yes">eft-3</italic> donor produced only 12.6% GFP-positive Rollers, the TEG- and RNA::TEG-modified <italic toggle="yes">eft-3</italic> donors produced 57.1% and 49% GFP-positive Rollers (<bold><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Figure 4C</xref></bold>). Similarly, GFP::CSR-1(+) Rollers increased from 8.8% (unmodified) to 28% (TEG) and 32.8% (RNA::TEG) (<bold><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Figure 4F</xref></bold>). TEG- and RNA::TEG-modified <italic toggle="yes">eft-3</italic> and <italic toggle="yes">csr-1</italic> donors produced &gt;50% GFP(+) non-Roller progeny compared to roughly 22% (<italic toggle="yes">eft-3</italic>) and 30% (<italic toggle="yes">csr-1</italic>) GFP(+) non-Rollers produced by the unmodified donor (<bold><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-5" hwp:rel-id="F4">Figure 4D</xref> and G</bold>). Every GFP(+) animal tested transmitted the edit to the next generation (<bold><xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-1" hwp:rel-id="F11">Figure S5A</xref> and <xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-2" hwp:rel-id="F11">B</xref></bold>). Thus, compared to the unmodified donors, the 5′-TEG and 5′-RNA::TEG donors substantially increase the frequency of <italic toggle="yes">gfp</italic> insertion by HDR in the <italic toggle="yes">C. elegans</italic> germline. Strikingly, end-modified donors frequently yielded more than 100 independent GFP(+) F1 progeny from a single injected hermaphrodite.</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4 xref-fig-4-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4.</label><caption hwp:id="caption-4"><p hwp:id="p-24">Modified donors promote precise editing in <italic toggle="yes">C. elegans.</italic> (A) Schematic showing end-modified dsDNA donors (25ng/µl) with short (∼35bp) homology arms to insert <italic toggle="yes">gfp</italic> tag. (B) Number of GFP expressing animals among entire F1 brood of two representative P0 animals for each donor type are plotted for <italic toggle="yes">eft-3p</italic> reporter locus. Fraction of F1 animals expressing GFP among (C) Roller and (D) non-Roller cohorts are plotted as percentage for <italic toggle="yes">eft-3p</italic> locus. Similarly, (E) number of GFP expressing animals among two representative broods, fraction of F1 animals expressing GFP among (F) Roller and (G) non-Roller cohorts are plotted for <italic toggle="yes">csr-1</italic> locus. Open bars (Rollers) and closed bars represent (non-Rollers) median. Number of GFP expressing animals among total number of animals scored per cohort are shown above the bars. n ≥4 broods for each donor condition. P-values were calculated using one-way ANOVA and in all cases end-modified donors were compared to unmodified donors (Tukey’s multiple comparisons test; ****P &lt; 0.0001; ***P &lt; 0.001; **P &lt; 0.01; *P&lt; 0.05; ns-not significant).</p></caption><graphic xlink:href="354480v2_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-9">5′-modified donors promote precision editing in vertebrate zygotes</title><p hwp:id="p-25">We next asked if donor 5′-modifications improve precision genome editing in zebrafish and mouse zygotes. For zebrafish genome editing, we designed 147-bp dsDNA donors to insert the 45-nt Avitag sequence into the 5′ end of the <italic toggle="yes">Hey2</italic> coding sequence (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Figure 5A</xref></bold>). Unmodified or end-modified donors were co-injected with Cas12a RNPs into one-cell embryos (see Methods), and editing efficiencies were quantified by high-throughput sequencing using genomic DNA isolated 24 hr after injection <sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref></sup>. Strikingly, the frequency of precise editing was 11-fold higher with the RNA::TEG (4.4%) donor than with the unmodified donor (0.4%)(<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Figure 5A</xref></bold>). The TEG-modified donor however failed to enhance precise editing in zebrafish zygotes (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Figure 5A</xref></bold>). The total level of editing was comparable in each condition as shown by the fraction of reads with indels (<bold><xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-1" hwp:rel-id="F12">Figure S6</xref>)</bold>.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6 xref-fig-5-7 xref-fig-5-8 xref-fig-5-9 xref-fig-5-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Figure 5.</label><caption hwp:id="caption-5"><p hwp:id="p-26">2′-OMe-RNA-TEG donors promote precise editing in vertebrate zygotes. (A) unmodified, TEG and 2′-OMe-RNA-TEG modified dsDNA donors were injected into zebrafish zygotes. dsDNA donor design to knock-in Avi-tag is shown on the top and the fraction of Illumina reads containing precise knock-in are plotted as percentages. Mean ± s.d for at least three independent replicates (two for unmodified donors) are plotted (B). Design of the dsDNA donors injected into mouse zygotes to precisely convert the coat color of albino mice (<italic toggle="yes">Tyr<sup>C</sup></italic>) to pigmented (<italic toggle="yes">Tyr<sup>C-Cor</sup></italic>) by editing C to G (underscored) along with six silent mutations (in red) is shown. Percentages of F0 founder mice with black coat are shown. (C) percentages of animals among HDR positive F0s that have uniform dark coat or mosaic coat color are plotted for unmodified and 5′ modified donors. (D) Representative pictures of 10 days old F0 mice with pigmented (HDR) or white (wt or indel) coat color are shown. One mosaic mouse (third from left) can be seen among the pups obtained with end-modified donor. (E) Donor design to knock-in V5 tag at the C-terminus of Sox2 is shown on the top. Percentage of founder animals containing perfect <italic toggle="yes">V5</italic> insertion at <italic toggle="yes">Sox2</italic> locus are shown for each donor type. HA: Homology Arms. P-values were calculated using one-way ANOVA (Tukey’s multiple comparisons test; ****P &lt; 0.0001; ***P &lt; 0.001; **P &lt; 0.01; *P&lt; 0.05; ns-not significant).</p></caption><graphic xlink:href="354480v2_fig5" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-27">To test whether RNA::TEG-modified donors enhance precise editing in mouse zygotes, we targeted the <italic toggle="yes">Tyrosinase (Tyr)</italic> and <italic toggle="yes">Sox2</italic> loci. First, we sought to convert the coat color of Swiss-Webster albino (<italic toggle="yes">Tyr<sup>c</sup></italic>) mice to a pigmented phenotype (<italic toggle="yes">Tyr<sup>c-cor</sup>; cor: corrected)</italic> using a donor to replace the serine 103 codon (TCT) with a cysteine (TGC) codon. The donor also introduces six silent mutations to prevent the guide RNA from directing cleavage of the edited locus (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Figure 5B</xref></bold>). We injected unmodified or RNA::TEG-modified donors with Cas9 RNPs into zygotes, transferred the embryos into pseudo-pregnant females, and quantified the repair efficiency by phenotyping the coat color of founder (F0) mice. The RNA::TEG-modified donor yielded more than twice as many pigmented F0 mice (37.9% uniform or mosaic) compared to unmodified donor (17.4%) (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Figure 5B</xref>, <xref ref-type="fig" rid="figs7" hwp:id="xref-fig-13-1" hwp:rel-id="F13">Figure S7A</xref></bold>). Strikingly, most (92%) of the edited founders produced by the RNA::TEG-modified donor had uniformly pigmented coats, whereas only 62.5% of the edited F0 produced by the unmodified donor had a uniformly pigmented coat color (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Figure 5C</xref>; <xref ref-type="fig" rid="figs7" hwp:id="xref-fig-13-2" hwp:rel-id="F13">Figure S7A</xref></bold>), suggesting that the RNA::TEG-modified donor promotes editing during early zygotic divisions. Representative images of F0 litters with dark coat color are shown in <bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-7" hwp:rel-id="F5">Figure 5D</xref></bold>. We confirmed that F0 mice with pigmented coat transmitted the corrected <italic toggle="yes">Tyr<sup>c-cor</sup></italic> allele to F1 pups (<bold><xref ref-type="fig" rid="figs7" hwp:id="xref-fig-13-3" hwp:rel-id="F13">Figure S7B</xref> and <xref ref-type="fig" rid="figs7" hwp:id="xref-fig-13-4" hwp:rel-id="F13">C</xref></bold>). Taken together, these results show that RNA::TEG donors are at least two-fold more efficient than unmodified donors in mouse zygote editing.</p><p hwp:id="p-28">Next, we sought to insert a sequence encoding an in-frame V5 epitope immediately before the stop codon at the 3′ end of the <italic toggle="yes">Sox2</italic> locus (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-8" hwp:rel-id="F5">Figure 5E</xref></bold>). We injected unmodified or RNA::TEG-modified donors with Cas9 RNPs into zygotes, transferred the embryos into pseudo-pregnant mice, and genotyped F0 progeny by PCR across the <italic toggle="yes">Sox2</italic> target site and Sanger sequencing. The V5 tag was precisely inserted into the <italic toggle="yes">Sox2</italic> locus in only 5.7% (n=35) of F0 animals from the injection with unmodified donor. By contrast, the RNA::TEG-modified donor resulted in precise insertion of V5 in 33.3% (n=24) of the F0 animals—a greater than 5-fold increase in precise editing (<bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-9" hwp:rel-id="F5">Figure 5E</xref> and <xref ref-type="fig" rid="figs8" hwp:id="xref-fig-14-1" hwp:rel-id="F14">Figure S8A</xref></bold>). All of the V5-positive founders tested (one F0 from the unmodified donor and six F0s from RNA::TEG-modified donor) transmitted the <italic toggle="yes">Sox2::V5</italic> allele to F1 progeny and the insertion was confirmed by Sanger sequencing (<bold><xref ref-type="fig" rid="figs8" hwp:id="xref-fig-14-2" hwp:rel-id="F14">Figure S8B</xref></bold> and <bold><xref ref-type="fig" rid="figs8" hwp:id="xref-fig-14-3" hwp:rel-id="F14">C</xref></bold>). Thus the 5′-RNA::TEG modification greatly improves the efficiency of precise genome editing in vertebrate model systems.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-10">5′-modifications suppress donor concatenation</title><p hwp:id="p-29">Upon delivery into animal cells or embryos, linear DNA molecules are known to form extensive homology-mediated and ligation-dependent concatemers (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Figure 6A</xref></bold>) <sup><xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">16</xref>–<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref></sup>. We reasoned that 5′ modifications to the donor might suppress the formation of concatemers, thereby making linear donors more available for HDR. To test this idea, we nucleofected 566 bp dsDNA donors into HEK293T cells, harvested cells over a course of 3 days, and assessed the formation of concatemers by Southern blot analysis. We found that the unmodified dsDNA formed concatemers within 1 hour after nucleofection. These concatemers were composed of two to several copies of the DNA, inferred from the presence of a ladder of bands on the Southern blot (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Figure 6B</xref></bold>). Concatemers of up to ten copies were present within 3 hours after nucleofection and peaked in abundance by 12 hours. Concatemer levels declined over the next 12 hours but persisted at low levels until at least 72 hours after nucleofection. By contrast, the TEG-modified DNA showed a marked delay in the formation and levels of multimers (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-3" hwp:rel-id="F6">Figure 6B</xref></bold>). Dimers and trimers gradually formed over the first 12 to 24 hours but were present at much lower levels than those formed by unmodified DNA. At late time points—24, 48, and 72 hours after transfection—we observed a greater fraction of TEG-modified DNA monomers than unmodified monomers (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-4" hwp:rel-id="F6">Figure 6B</xref></bold>). These results suggest that the 5′-TEG modification significantly suppresses concatemer formation.</p><fig id="fig6" position="float" orientation="portrait" fig-type="figure" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2 xref-fig-6-3 xref-fig-6-4 xref-fig-6-5 xref-fig-6-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Figure 6.</label><caption hwp:id="caption-6"><p hwp:id="p-30">End-modifications suppress formation of donor concatemers. (A) Model for mechanisms of concatemer formation is shown. (B) Southern blot of unmodified and TEG modified dsDNA (566bp) nucleofected into HEK293T cells and collected at indicated time points. Concatemerization of unmodified DNA is visualized as ladders; 566bp DNA and 13kb long DNA are used as size markers (m). Number of Guide-seq reads with unmodified and TEG modified short dsDNA (34bp) integration for, (C) whole genome and (D) on-target (<italic toggle="yes">ARHGEF9)</italic> and six previously validated off-target loci are plotted. Data from two biological replicates is shown.</p></caption><graphic xlink:href="354480v2_fig6" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-11">End-modifications suppress direct ligation of short DNA into DSBs</title><p hwp:id="p-31">To determine if TEG modification suppresses the direct ligation of TEG-modified linear molecules into chromosomal DSBs, we performed GUIDE-seq analyses <sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref></sup>, which measures the incorporation of short (34nt) dsDNA into on-target and off-target DSBs. We targeted the <italic toggle="yes">ARHGEF9</italic> locus, previously characterized for off-target editing <sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup>. Strikingly, the TEG-modified DNA produced 19-fold fewer GUIDE-seq reads (genome wide) than did the unmodified DNA (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-5" hwp:rel-id="F6">Figure 6C</xref>)</bold>. The number of TEG-modified DNA insertions obtained at the on-target cut site in the <italic toggle="yes">ARHGEF9</italic> locus and at the top 6 off target sites were dramatically reduced, ranging from 15-fold to 6-fold lower compared to insertions of the unmodified DNA (<bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-6" hwp:rel-id="F6">Figure 6D</xref></bold>). Taken together these data suggest that TEG-modifications suppress direct ligation of donor molecules both to each other and to chromosomal DSBs.</p></sec></sec><sec id="s3" hwp:id="sec-9"><title hwp:id="title-12">Discussion</title><p hwp:id="p-32">Here we have explored how several types of chemical modifications to the repair template DNA affect the efficiency of precise homology-dependent repair. In mammalian cells, donors containing simple modifications such as TEG or 2′OMe-RNA::TEG on their 5′ ends improved HDR efficacy. These modifications increased the potency of single- and double-stranded DNA (long and short) donors, allowing efficient editing at significantly lower amounts. Modifying the ends of the donors suppressed concatemer formation and significantly reduced random integration of short dsDNA at chromosomal DSBs.</p><p hwp:id="p-33">End modifications affected long and short donors differently in mammalian cells. On long donors end modification caused a ∼2-to-5-fold increase in HDR frequency (total efficacy) compared to unmodified donors and did so without changing the donor concentration where efficacy reached its plateau. In contrast, on short donors end modifications did not increase the maximal efficacy of HDR, but instead dramatically reduced the amount of donor required to reach that maximal level. Put another way, long DNA donors exhibited both increased potency and maximal efficacy when modified, while short ssODN and dsDNA donors exhibited increased potency but no increase in maximal efficacy. This difference requires further study but could be explained if shorter donors and longer DNA donors experience different dose-limiting barriers. For example, the dose-limiting toxicity of ssODNs could be driven by total number of free DNA ends per cell, while longer molecules could encounter dose-limiting toxicity driven by total DNA mass. Consistent with this idea, unmodified long dsDNA donors begin to plateau in efficacy at nearly 4-fold more mass, but ∼10-fold lower molar amounts than ssODNs. When end-modified, both types of donor exhibit similar maximal efficacy in the 1 to 2 pmol range.</p><p hwp:id="p-34">RNA::TEG-modified donors significantly increased the levels of precision editing in three different model organisms (<italic toggle="yes">C. elegans</italic>, zebrafish, and mice). In all three animals, high HDR efficiencies were achieved using end-modified dsDNA donors, that in some cases approached efficiencies previously observed for ssODN donors <sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">27</xref>, <xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref></sup>. Importantly, precise insertions were obtained with relatively short homology arms. For example, in mouse zygote injections, we used donors with homology arms of less than 90 bp, similar to typical arm lengths used for ssODN donors <sup><xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref></sup> and at relatively low concentrations (1 ng/µl).</p><p hwp:id="p-35">How do end-modifications help increase the efficacy of the donors? Our findings suggest that they do so, in part, by suppressing non-homologous end-joining reactions. In several systems dsDNA donors have been shown to quickly form extrachromosomal arrays <sup><xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-3" hwp:rel-id="ref-16">16</xref>–<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">18</xref></sup> and may do so directly in the cytoplasm <sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref></sup>. For example, DNA delivered into the cytoplasm of the <italic toggle="yes">C. elegans</italic> gonadal syncytium gains entry into oocytes over a 24 hour period in a manner more consistent with cytoplasmic flow than with direct nuclear uptake by germ nuclei <sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-3" hwp:rel-id="ref-28">28</xref></sup>, and transformants established in this way have been shown to contain concatenated arrays of injected DNA, several hundred kilobases in length, which then partition to progeny in a non-Mendelian fashion as extrachromosomal elements <sup><xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-3" hwp:rel-id="ref-18">18</xref>, <xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref></sup>. Integration of similar extrachromosomal arrays into the host genome have been reported in zebrafish and mouse zygotes <sup><xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>, <xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref></sup>. Thus, the suppression of donor concatemer formation by 5′ modified donors could increase the effective molar amounts of donor available for precise repair of the target double strand break. Similarly, once in the nucleus, the suppression of direct ligation to chromosomal DNA through end-joining reactions could further increase precision repair. Perhaps consistent with suppression of concatenation as a major mechanism of action, it is intriguing that modification of a single end was nearly as effective as modifications to both ends of the donor. In principle, a single end modification would limit concatenation to dimer formation. Similarly, modification of a single end could prevent donors from ligating into circles which might then concatenate further through HDR.</p><p hwp:id="p-36">In addition to increasing the amount of available donor molecules, another possible benefit of suppressing end-joining reactions is that the free ends of the donor might then be available to participate in the HDR mechanism (for example, by assembling elements of the DSB repair machinery directly on the free 3′-end of the donor). We found that a free unmodified 3′ end was required for efficient HDR. Thus, by suppressing ligation, the 5′ modification in effect maintains available 3′ ends, perhaps to prime repair synthesis.</p><p hwp:id="p-37">In previous studies, fluorescent and amine modifications to the 5′ and 3′ termini of ssODN donors did not improve HDR efficacy over unmodified donors <sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref></sup>. However, these studies were performed using doses 50-fold higher than the optimal dose for modified donors determined here. Similarly, phosphorothioate (PS) linkages were shown to improve HDR at doses much higher than the optimal dose for modified ssODNs in our study <sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup>. In our study, ssODNs with PS linkages did not improve HDR at doses where RNA::TEG- and TEG-modified donors were most efficacious. While our study was in preparation <sup><xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref></sup>, three studies explored donors with 5′-end modifications. One study showed that the addition of biotin improved HDR and favored single copy insertion in the rice fish medaka <sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref></sup>. The biotin moiety was attached to the donor via a polyethylene glycol (PEG) linker, but the study did not explore donors with PEG alone. Yu et al. (2020) showed that PEG10 with a 6-carbon linker boosted precise GFP insertions in vertebrate cells similar to those reported here for TEG- and RNA::TEG-modified donors, and at similar concentrations to those we employed <sup><xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref></sup>. The third study describes the suppression of NHEJ-mediated insertions using donors with 5′-Biotin::PEG or 5′-ssDNA::PEG moieties <sup><xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref></sup>. Our studies are in agreement with these findings and extend them to additional modifications and to <italic toggle="yes">in vivo</italic> genome-editing applications in three animal systems.</p><p hwp:id="p-38">We do not understand why donors modified with TEG and RNA::TEG performed similarly in <italic toggle="yes">C. elegans</italic>, while RNA::TEG was consistently superior to TEG alone in zebrafish and human cells. The <italic toggle="yes">C. elegans</italic> system is unique in that it targets meiotic pachytene nuclei that are actively engaged in HDR. Perhaps donors must persist longer to engage the DSB repair machinery in mitotic cells. The RNA::TEG modification might therefore facilitate editing in mitotic cells by providing better protection from nuclease activity compared to TEG alone. PS linkages are known to protect against nuclease activity <sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-2" hwp:rel-id="ref-4">4</xref></sup>, and it will therefore be interesting to explore whether a combination of internal (e.g., PS linkages) and terminal (e.g., 5′-RNA::TEG or 5′-TEG) modifications can further increase HDR efficacy. Indeed, our results should incite the search for additional chemistries that could boost donor stability while still allowing the donor to serve as a template for repair polymerases; some such studies are underway in our laboratories. Future studies will also need to explore whether the incorporation of donor chemistries will synergize with other methods that stimulate HDR <sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>, <xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>, <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>, <xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">15</xref>, 42–<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref></sup>.</p></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-13">Acknowledgements</title><p hwp:id="p-39">This work was funded by Howard Hughes Medical Institute (C.C.M.), NIH R37GM058800-23 (C.C.M), institutional funds from University of Massachusetts Medical School (E.J.S and J.K.W), NIH UG3 TR002668 (E.J.S and J.K.W), NIH/NHLBI R35 HL140017 (N.D.L) and NIH/OD R21 OD030004 (N.D.L). We thank Darryl Conte, Jr. for critical reading of the manuscript, Scot Wolfe for sharing the Cas9 expression plasmid, Julia Rembetsy-Brown for maintaining <italic toggle="yes">Sox2::V5</italic> mouse colony and Alireza Edraki for help with PCRs of some human dsDNA donors. Biorender was used to generate some of the graphics in figures. We thank the UMass Medical School Deep Sequencing Core for their assistance with the Illumina and PacBio sequencing.</p></ack><sec id="s3a" hwp:id="sec-10"><title hwp:id="title-14">Competing interests</title><p hwp:id="p-40">The authors (K.S.G, A.M, G.A.D, H.G, J.K.W, E.J.S and C.C.M) have a patent application pending related to the findings described. Craig C. Mello is a co-founder and Scientific Advisory Board member of CRISPR Therapeutics, and Erik J. Sontheimer is a co-founder and Scientific Advisory Board member of Intellia Therapeutics.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-15">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Lin S."><surname>Lin</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Staahl B.T."><surname>Staahl</surname>, <given-names>B.T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alla R.K."><surname>Alla</surname>, <given-names>R.K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Doudna J.A"><surname>Doudna</surname>, <given-names>J.A</given-names></string-name>. <article-title hwp:id="article-title-2">Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery</article-title>. <source hwp:id="source-1">Elife</source> <volume>3</volume>, <fpage>e04766</fpage> (<year>2014</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Wienert B."><surname>Wienert</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-3">Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair</article-title>. <source hwp:id="source-2">Nat Commun</source> <volume>11</volume>, <fpage>2109</fpage> (<year>2020</year>).</citation></ref><ref id="c3" hwp:id="ref-3"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Nambiar T.S."><surname>Nambiar</surname>, <given-names>T.S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-4">Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant</article-title>. <source hwp:id="source-3">Nat Commun</source> <volume>10</volume>, <fpage>3395</fpage> (<year>2019</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1 xref-ref-4-2"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Renaud J.B."><surname>Renaud</surname>, <given-names>J.B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-5">Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases</article-title>. <source hwp:id="source-4">Cell Rep</source> <volume>14</volume>, <fpage>2263</fpage>–<lpage>2272</lpage> (<year>2016</year>).</citation></ref><ref id="c5" hwp:id="ref-5"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Rees H.A."><surname>Rees</surname>, <given-names>H.A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yeh W.H."><surname>Yeh</surname>, <given-names>W.H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Liu D.R"><surname>Liu</surname>, <given-names>D.R</given-names></string-name>. <article-title hwp:id="article-title-6">Development of hRad51-Cas9 nickase fusions that mediate HDR without double-stranded breaks</article-title>. <source hwp:id="source-5">Nat Commun</source> <volume>10</volume>, <fpage>2212</fpage> (<year>2019</year>).</citation></ref><ref id="c6" hwp:id="ref-6"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Jayathilaka K."><surname>Jayathilaka</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-7">A chemical compound that stimulates the human homologous recombination protein RAD51</article-title>. <source hwp:id="source-6">Proc Natl Acad Sci U S A</source> <volume>105</volume>, <fpage>15848</fpage>–<lpage>15853</lpage> (<year>2008</year>).</citation></ref><ref id="c7" hwp:id="ref-7"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Pinder J."><surname>Pinder</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salsman J."><surname>Salsman</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Dellaire G"><surname>Dellaire</surname>, <given-names>G</given-names></string-name>. <article-title hwp:id="article-title-8">Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing</article-title>. <source hwp:id="source-7">Nucleic Acids Res</source> <volume>43</volume>, <fpage>9379</fpage>–<lpage>9392</lpage> (<year>2015</year>).</citation></ref><ref id="c8" hwp:id="ref-8"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Riesenberg S."><surname>Riesenberg</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Maricic T"><surname>Maricic</surname>, <given-names>T</given-names></string-name>. <article-title hwp:id="article-title-9">Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells</article-title>. <source hwp:id="source-8">Nat Commun</source> <volume>9</volume>, <fpage>2164</fpage> (<year>2018</year>).</citation></ref><ref id="c9" hwp:id="ref-9"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Yu C."><surname>Yu</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Small molecules enhance CRISPR genome editing in pluripotent stem cells</article-title>. <source hwp:id="source-9">Cell Stem Cell</source> <volume>16</volume>, <fpage>142</fpage>–<lpage>147</lpage> (<year>2015</year>).</citation></ref><ref id="c10" hwp:id="ref-10"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Canny M.D."><surname>Canny</surname>, <given-names>M.D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-11">Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency</article-title>. <source hwp:id="source-10">Nat Biotechnol</source> <volume>36</volume>, <fpage>95</fpage>–<lpage>102</lpage> (<year>2018</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.11" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Robert F."><surname>Robert</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barbeau M."><surname>Barbeau</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ethier S."><surname>Ethier</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dostie J."><surname>Dostie</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Pelletier J"><surname>Pelletier</surname>, <given-names>J</given-names></string-name>. <article-title hwp:id="article-title-12">Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing</article-title>. <source hwp:id="source-11">Genome Med</source> <volume>7</volume>, <issue>93</issue> (<year>2015</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Frank-Vaillant M."><surname>Frank-Vaillant</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Marcand S"><surname>Marcand</surname>, <given-names>S</given-names></string-name>. <article-title hwp:id="article-title-13">Transient stability of DNA ends allows nonhomologous end joining to precede homologous recombination</article-title>. <source hwp:id="source-12">Mol Cell</source> <volume>10</volume>, <fpage>1189</fpage>–<lpage>1199</lpage> (<year>2002</year>).</citation></ref><ref id="c13" hwp:id="ref-13"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Mao Z."><surname>Mao</surname>, <given-names>Z.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bozzella M."><surname>Bozzella</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seluanov A."><surname>Seluanov</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gorbunova V"><surname>Gorbunova</surname>, <given-names>V</given-names></string-name>. <article-title hwp:id="article-title-14">Comparison of nonhomologous end joining and homologous recombination in human cells</article-title>. <source hwp:id="source-13">DNA Repair (Amst</source><italic toggle="yes">)</italic> <volume>7</volume>, <fpage>1765</fpage>–<lpage>1771</lpage> (<year>2008</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Chu V.T."><surname>Chu</surname>, <given-names>V.T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-15">Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells</article-title>. <source hwp:id="source-14">Nat Biotechnol</source> <volume>33</volume>, <fpage>543</fpage>–<lpage>548</lpage> (<year>2015</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Maruyama T."><surname>Maruyama</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-16">Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining</article-title>. <source hwp:id="source-15">Nat Biotechnol</source> <volume>33</volume>, <fpage>538</fpage>–<lpage>542</lpage> (<year>2015</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2 xref-ref-16-3"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Perucho M."><surname>Perucho</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hanahan D."><surname>Hanahan</surname>, <given-names>D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wigler M"><surname>Wigler</surname>, <given-names>M</given-names></string-name>. <article-title hwp:id="article-title-17">Genetic and physical linkage of exogenous sequences in transformed cells</article-title>. <source hwp:id="source-16">Cell</source> <volume>22</volume>, <fpage>309</fpage>–<lpage>317</lpage> (<year>1980</year>).</citation></ref><ref id="c17" hwp:id="ref-17"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Folger K.R."><surname>Folger</surname>, <given-names>K.R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wong E.A."><surname>Wong</surname>, <given-names>E.A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wahl G."><surname>Wahl</surname>, <given-names>G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Capecchi M.R"><surname>Capecchi</surname>, <given-names>M.R</given-names></string-name>. <article-title hwp:id="article-title-18">Patterns of integration of DNA microinjected into cultured mammalian cells: evidence for homologous recombination between injected plasmid DNA molecules</article-title>. <source hwp:id="source-17">Mol Cell Biol</source> <volume>2</volume>, <fpage>1372</fpage>–<lpage>1387</lpage> (<year>1982</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2 xref-ref-18-3"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Mello C.C."><surname>Mello</surname>, <given-names>C.C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kramer J.M."><surname>Kramer</surname>, <given-names>J.M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stinchcomb D."><surname>Stinchcomb</surname>, <given-names>D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ambros V"><surname>Ambros</surname>, <given-names>V</given-names></string-name>. <article-title hwp:id="article-title-19">Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences</article-title>. <source hwp:id="source-18">EMBO J</source> <volume>10</volume>, <fpage>3959</fpage>–<lpage>3970</lpage> (<year>1991</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Stuart G.W."><surname>Stuart</surname>, <given-names>G.W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="McMurray J.V."><surname>McMurray</surname>, <given-names>J.V.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Westerfield M"><surname>Westerfield</surname>, <given-names>M</given-names></string-name>. <article-title hwp:id="article-title-20">Replication, integration and stable germ-line transmission of foreign sequences injected into early zebrafish embryos</article-title>. <source hwp:id="source-19">Development</source> <volume>103</volume>, <fpage>403</fpage>–<lpage>412</lpage> (<year>1988</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Lacy E."><surname>Lacy</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roberts S."><surname>Roberts</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Evans E.P."><surname>Evans</surname>, <given-names>E.P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Burtenshaw M.D."><surname>Burtenshaw</surname>, <given-names>M.D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Costantini F.D"><surname>Costantini</surname>, <given-names>F.D</given-names></string-name>. <article-title hwp:id="article-title-21">A foreign beta-globin gene in transgenic mice: integration at abnormal chromosomal positions and expression in inappropriate tissues</article-title>. <source hwp:id="source-20">Cell</source> <volume>34</volume>, <fpage>343</fpage>–<lpage>358</lpage> (<year>1983</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Certo M.T."><surname>Certo</surname>, <given-names>M.T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">Tracking genome engineering outcome at individual DNA breakpoints</article-title>. <source hwp:id="source-21">Nat Methods</source> <volume>8</volume>, <fpage>671</fpage>–<lpage>676</lpage> (<year>2011</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.22" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Iyer S."><surname>Iyer</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-23">Efficient Homology-directed Repair with Circular ssDNA Donors</article-title>. <source hwp:id="source-22">bioRxiv</source>, <volume>864199</volume> (<year>2019</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Richardson C.D."><surname>Richardson</surname>, <given-names>C.D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ray G.J."><surname>Ray</surname>, <given-names>G.J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="DeWitt M.A."><surname>DeWitt</surname>, <given-names>M.A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Curie G.L."><surname>Curie</surname>, <given-names>G.L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Corn J.E"><surname>Corn</surname>, <given-names>J.E</given-names></string-name>. <article-title hwp:id="article-title-24">Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA</article-title>. <source hwp:id="source-23">Nat Biotechnol</source> <volume>34</volume>, <fpage>339</fpage>–<lpage>344</lpage> (<year>2016</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Glaser A."><surname>Glaser</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="McColl B."><surname>McColl</surname>, <given-names>B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Vadolas J"><surname>Vadolas</surname>, <given-names>J</given-names></string-name>. <article-title hwp:id="article-title-25">GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing</article-title>. <source hwp:id="source-24">Mol Ther Nucleic Acids</source> <volume>5</volume>, <fpage>e334</fpage> (<year>2016</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Cho S.W."><surname>Cho</surname>, <given-names>S.W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee J."><surname>Lee</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carroll D."><surname>Carroll</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim J.S."><surname>Kim</surname>, <given-names>J.S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lee J"><surname>Lee</surname>, <given-names>J</given-names></string-name>. <article-title hwp:id="article-title-26">Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins</article-title>. <source hwp:id="source-25">Genetics</source> <volume>195</volume>, <fpage>1177</fpage>–<lpage>1180</lpage> (<year>2013</year>).</citation></ref><ref id="c26" hwp:id="ref-26"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Paix A."><surname>Paix</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Folkmann A."><surname>Folkmann</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rasoloson D."><surname>Rasoloson</surname>, <given-names>D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Seydoux G."><surname>Seydoux</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-27">High Efficiency, Homology-Directed Genome Editing in Caenorhabditis elegans Using CRISPR-Cas9 Ribonucleoprotein Complexes</article-title>. <source hwp:id="source-26">Genetics</source> <volume>201</volume>, <fpage>47</fpage>–<lpage>54</lpage> (<year>2015</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Dokshin G.A."><surname>Dokshin</surname>, <given-names>G.A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ghanta K.S."><surname>Ghanta</surname>, <given-names>K.S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Piscopo K.M."><surname>Piscopo</surname>, <given-names>K.M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mello C.C"><surname>Mello</surname>, <given-names>C.C</given-names></string-name>. <article-title hwp:id="article-title-28">Robust Genome Editing with Short Single-Stranded and Long, Partially Single-Stranded DNA Donors in Caenorhabditis elegans</article-title>. <source hwp:id="source-27">Genetics</source> <volume>210</volume>, <fpage>781</fpage>–<lpage>787</lpage> (<year>2018</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2 xref-ref-28-3"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Ghanta K.S."><surname>Ghanta</surname>, <given-names>K.S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mello C.C"><surname>Mello</surname>, <given-names>C.C</given-names></string-name>. <article-title hwp:id="article-title-29">Melting dsDNA Donor Molecules Greatly Improves Precision Genome Editing in Caenorhabditis elegans</article-title>. <source hwp:id="source-28">Genetics</source> <volume>216</volume>, <fpage>643</fpage>–<lpage>650</lpage> (<year>2020</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Liu P."><surname>Liu</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-30">Enhanced Cas12a editing in mammalian cells and zebrafish</article-title>. <source hwp:id="source-29">Nucleic Acids Res</source> <volume>47</volume>, <fpage>4169</fpage>–<lpage>4180</lpage> (<year>2019</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Tsai S.Q."><surname>Tsai</surname>, <given-names>S.Q.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-31">GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases</article-title>. <source hwp:id="source-30">Nat Biotechnol</source> <volume>33</volume>, <fpage>187</fpage>–<lpage>197</lpage> (<year>2015</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.31" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Amrani N."><surname>Amrani</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-32">NmeCas9 is an intrinsically high-fidelity genome-editing platform</article-title>. <source hwp:id="source-31">Genome Biol</source> <volume>19</volume>, <issue>214</issue> (<year>2018</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Kan Y."><surname>Kan</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ruis B."><surname>Ruis</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Takasugi T."><surname>Takasugi</surname>, <given-names>T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hendrickson E.A"><surname>Hendrickson</surname>, <given-names>E.A</given-names></string-name>. <article-title hwp:id="article-title-33">Mechanisms of precise genome editing using oligonucleotide donors</article-title>. <source hwp:id="source-32">Genome Res</source> <volume>27</volume>, <fpage>1099</fpage>–<lpage>1111</lpage> (<year>2017</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.33" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Quadros R.M."><surname>Quadros</surname>, <given-names>R.M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-34">Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins</article-title>. <source hwp:id="source-33">Genome Biol</source> <volume>18</volume>, <issue>92</issue> (<year>2017</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Forbes D.J."><surname>Forbes</surname>, <given-names>D.J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kirschner M.W."><surname>Kirschner</surname>, <given-names>M.W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Newport J.W"><surname>Newport</surname>, <given-names>J.W</given-names></string-name>. <article-title hwp:id="article-title-35">Spontaneous formation of nucleus-like structures around bacteriophage DNA microinjected into Xenopus eggs</article-title>. <source hwp:id="source-34">Cell</source> <volume>34</volume>, <fpage>13</fpage>–<lpage>23</lpage> (<year>1983</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Stinchcomb D.T."><surname>Stinchcomb</surname>, <given-names>D.T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shaw J.E."><surname>Shaw</surname>, <given-names>J.E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carr S.H."><surname>Carr</surname>, <given-names>S.H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hirsh D"><surname>Hirsh</surname>, <given-names>D</given-names></string-name>. <article-title hwp:id="article-title-36">Extrachromosomal DNA transformation of Caenorhabditis elegans</article-title>. <source hwp:id="source-35">Mol Cell Biol</source> <volume>5</volume>, <fpage>3484</fpage>–<lpage>3496</lpage> (<year>1985</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Costantini F."><surname>Costantini</surname>, <given-names>F.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lacy E"><surname>Lacy</surname>, <given-names>E</given-names></string-name>. <article-title hwp:id="article-title-37">Introduction of a rabbit beta-globin gene into the mouse germ line</article-title>. <source hwp:id="source-36">Nature</source> <volume>294</volume>, <fpage>92</fpage>–<lpage>94</lpage> (<year>1981</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.37" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Lee K."><surname>Lee</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-38">Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering</article-title>. <source hwp:id="source-37">Elife</source> <volume>6</volume> (<year>2017</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.38" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Ghanta K.S."><surname>Ghanta</surname>, <given-names>K.S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-39">5′ Modifications Improve Potency and Efficacy of DNA Donors for Precision Genome Editing</article-title>. <source hwp:id="source-38">bioRxiv</source>, <volume>354480</volume> (<year>2018</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.39" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Gutierrez-Triana J.A."><surname>Gutierrez-Triana</surname>, <given-names>J.A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-40">Efficient single-copy HDR by 5’ modified long dsDNA donors</article-title>. <source hwp:id="source-39">Elife</source> <volume>7</volume> (<year>2018</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Yu Y."><surname>Yu</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-41">An efficient gene knock-in strategy using 5’-modified double-stranded DNA donors with short homology arms</article-title>. <source hwp:id="source-40">Nat Chem Biol</source> <volume>16</volume>, <fpage>387</fpage>–<lpage>390</lpage> (<year>2020</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.41" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Canaj H."><surname>Canaj</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-42">Deep profiling reveals substantial heterogeneity of integration outcomes in CRISPR knock-in experiments</article-title>. <source hwp:id="source-41">bioRxiv</source>, <volume>841098</volume> (<year>2019</year>).</citation></ref><ref id="c42" hwp:id="ref-42"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Gutschner T."><surname>Gutschner</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haemmerle M."><surname>Haemmerle</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Genovese G."><surname>Genovese</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Draetta G.F."><surname>Draetta</surname>, <given-names>G.F.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Chin L"><surname>Chin</surname>, <given-names>L</given-names></string-name>. <article-title hwp:id="article-title-43">Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair</article-title>. <source hwp:id="source-42">Cell Rep</source> <volume>14</volume>, <fpage>1555</fpage>–<lpage>1566</lpage> (<year>2016</year>).</citation></ref><ref id="c43" hwp:id="ref-43"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Yang D."><surname>Yang</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-44">Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases</article-title>. <source hwp:id="source-43">Sci Rep</source> <volume>6</volume>, <fpage>21264</fpage> (<year>2016</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Ling X."><surname>Ling</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates</article-title>. <source hwp:id="source-44">Sci Adv</source> <volume>6</volume>, <fpage>eaaz0051</fpage> (<year>2020</year>).</citation></ref></ref-list><sec hwp:id="sec-11"><title hwp:id="title-16">Supplementary Materials</title><sec hwp:id="sec-12"><title hwp:id="title-17">Supplementary Figures</title><fig id="figs1" position="float" orientation="portrait" fig-type="figure" hwp:id="F7" hwp:rev-id="xref-fig-7-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">figs1</object-id><label>Figure S1:</label><caption hwp:id="caption-7"><p hwp:id="p-41">2′OMe-RNA at 5′ ends of donors promote HDR in mammalian cells. Editing efficacy plotted as percentage of (A) GFP+ (HDR) and (B) mCherry+ (NHEJ) HEK293T TLR cells at different amounts of unmodified, 2′OMe-RNA::TEG-modified and PNA::NLS-annealed dsDNA donors. Same unmodified controls are used in <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-10" hwp:rel-id="F1">Figure 1</xref> B and C. Addition of PNA (without NLS) to unmodified or end-modified donors does not further improve HDR efficiency in mammalian cells. 0.8 pmol of each type of donor was annealed to PNA (0.1 to 10 pmol). Editing efficiency was plotted as percentage of (C) GFP+ (HDR) cells and (D) mCherry+ (NHEJ) cells. Percentages were calculated by sorting the cells through flow cytometry (see Methods)</p></caption><graphic xlink:href="354480v2_figs1" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><fig id="figs2" position="float" orientation="portrait" fig-type="figure" hwp:id="F8" hwp:rev-id="xref-fig-8-1 xref-fig-8-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">figs2</object-id><label>Figure S2.</label><caption hwp:id="caption-8"><p hwp:id="p-42">RNA::TEG donors with short (90bp) homology arms are more potent than unmodified donors at <italic toggle="yes">EMX1</italic> locus. Fraction of precise reads is plotted as percentage of total Illumina reads obtained at various amounts of dsDNA donors into K562 cells. Cas9 RNPs and dsDNA donors were nucleofected into K562 cells and harvested after 3 days.</p></caption><graphic xlink:href="354480v2_figs2" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><fig id="figs3" position="float" orientation="portrait" fig-type="figure" hwp:id="F9" hwp:rev-id="xref-fig-9-1 xref-fig-9-2 xref-fig-9-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F9</object-id><object-id pub-id-type="publisher-id">figs3</object-id><label>Figure S3.</label><caption hwp:id="caption-9"><p hwp:id="p-43">2′OMe-RNA::TEG modification of single-stranded DNA donors results in reduced imprecise editing. (A) Imprecise editing efficiency plotted as percentage of mCherry(+)HEK293T TLR cells at different amounts of unmodified or TEG::2′OMe-RNA-modified ssDNA donor. Fraction of cells expressing GFP is plotted in <xref ref-type="fig" rid="figs3" hwp:id="xref-fig-9-3" hwp:rel-id="F9">Figure. 3A</xref>. (B) Imprecise editing plotted as percentage of GFP(-) and BFP(-) cells in GFP-to-BFP reporter K562 cells using different amounts of unmodified and TEG::2′OMe-RNA-modifed ssODN donors. Fraction of cells expresing BFP is plotted in <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Figure. 3B</xref></p></caption><graphic xlink:href="354480v2_figs3" position="float" orientation="portrait" hwp:id="graphic-9"/></fig><fig id="figs4" position="float" orientation="portrait" fig-type="figure" hwp:id="F10" hwp:rev-id="xref-fig-10-1 xref-fig-10-2 xref-fig-10-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F10</object-id><object-id pub-id-type="publisher-id">figs4</object-id><label>Figure S4.</label><caption hwp:id="caption-10"><p hwp:id="p-44">Effects of terminal and non-terminal modifications of ssODN donors on HDR efficacy. Editing efficacy of GFP-to-BFP conversion in K562 cells using 0.5 pmol of ssODN donors modified at the 5′ end alone, the 3′ end alone, or at both the 5′ and 3′ ends, with phosphorothioate (PS), TEG, 2′OMe-RNA, or 2′OMe-RNA::TEG, plotted as percentage of BFP(+) cells (HDR). This figure consists of the data shown in <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Figure. 3C</xref> along with other controls and modifications to the donors. Note that the PS modification is at the 5′ or 3′ internal linkages while TEG modifications are appended to the 5′ or 3′ terminus. All data points represent a mean of at least three independent replicates and all error bars represent standard deviation. P-values were calculated using one-way ANOVA and in all cases end-modified donors were compared to the unmodified donor (Tukey’s multiple comparisons test; ****P &lt; 0.0001; ***P &lt; 0.001; **P &lt; 0.01; *P&lt; 0.05; ns-not significant).</p></caption><graphic xlink:href="354480v2_figs4" position="float" orientation="portrait" hwp:id="graphic-10"/></fig><fig id="figs5" position="float" orientation="portrait" fig-type="figure" hwp:id="F11" hwp:rev-id="xref-fig-11-1 xref-fig-11-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F11</object-id><object-id pub-id-type="publisher-id">figs5</object-id><label>Figure S5.</label><caption hwp:id="caption-11"><p hwp:id="p-45">Precise insertions are germline transmitted in <italic toggle="yes">C. elegans</italic>. (A) Schematic representaiton of the eft3p-gfp (partial) locus edited with dsDNA donors with or without end-modifucationS in <italic toggle="yes">C. elegans</italic>. Precisely edited animals express GFP signal ubiqutiously. (B) GFP-postive F1 animals were cloned and their progeny (F2s) were scored for GFP expression. Number of F1s that produced GFP expressing F2 in a mendelian fashion are shown under F2 transmission column.</p></caption><graphic xlink:href="354480v2_figs5" position="float" orientation="portrait" hwp:id="graphic-11"/></fig><fig id="figs6" position="float" orientation="portrait" fig-type="figure" hwp:id="F12" hwp:rev-id="xref-fig-12-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F12</object-id><object-id pub-id-type="publisher-id">figs6</object-id><label>Figure S6</label><caption hwp:id="caption-12"><p hwp:id="p-46">: Indel efficincies in zebrafish zygotes. (A) Fraction of reads with indels among total reads obtained in experiments with either no donor, unmodified or end-modified donors are plotted as percentage. Precise repair (HDR) efficiencies are shown in <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-10" hwp:rel-id="F5">Figure 5A</xref>.</p></caption><graphic xlink:href="354480v2_figs6" position="float" orientation="portrait" hwp:id="graphic-12"/></fig><fig id="figs7" position="float" orientation="portrait" fig-type="figure" hwp:id="F13" hwp:rev-id="xref-fig-13-1 xref-fig-13-2 xref-fig-13-3 xref-fig-13-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS7</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F13</object-id><object-id pub-id-type="publisher-id">figs7</object-id><label>Figure S7.</label><caption hwp:id="caption-13"><p hwp:id="p-47">5′ modified donors improve targetted editing efficiency at the <italic toggle="yes">Tyr</italic> locus in Albino mice. (A) Micro-injection information and HDR efficiencies obtained for unmodified and 2′OMe-RNA::TEG modified donors. (B) Germline transmission of the edited <italic toggle="yes">Tyr<sup>c-cor</sup></italic> allele was confirmed by crossing some of the pigmented F0 mice to Swiss webster mice (<italic toggle="yes">Tyr<sup>c</sup></italic>) and phenotyping their F1 progeny (C) Representative images of F1 litters obtained from crosses for germline transmission tests.</p></caption><graphic xlink:href="354480v2_figs7" position="float" orientation="portrait" hwp:id="graphic-13"/></fig><fig id="figs8" position="float" orientation="portrait" fig-type="figure" hwp:id="F14" hwp:rev-id="xref-fig-14-1 xref-fig-14-2 xref-fig-14-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS8</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F14</object-id><object-id pub-id-type="publisher-id">figs8</object-id><label>Figure S8.</label><caption hwp:id="caption-14"><p hwp:id="p-48">5′ modified donors imporve targetted editing efficiency at the <italic toggle="yes">Sox2</italic> locus in mouse zygotes. (A) Microinjection information and HDR efficiencies obtained using unmodified and 2′OMe-RNA::TEG modified donors are shown. (B) Germline transmission rates of the <italic toggle="yes">Sox2::V5</italic> allele was confirmed by crossing the HDR positive F0 mice with WT mice and genotyping the F1 pups. (C). Sanger sequencing trace of <italic toggle="yes">Sox2::V5</italic> allele in F1 mice.</p></caption><graphic xlink:href="354480v2_figs8" position="float" orientation="portrait" hwp:id="graphic-14"/></fig><fig id="figs9" position="float" orientation="portrait" fig-type="figure" hwp:id="F15" hwp:rev-id="xref-fig-15-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;354480v2/FIGS9</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F15</object-id><object-id pub-id-type="publisher-id">figs9</object-id><label>Figure S9.</label><caption hwp:id="caption-15"><p hwp:id="p-49">Flow cytometry analysis to determine the percentage of precise and imprecise genome editing events. The gating strategies used for HEK293T TLR cells (Top) and K562 GFP+ cells (Bottom) are shown. Cells were first gated based on forward and side scattering to select “live” cells (A, E), and then gated to select singlets (B, F). Quadrant gates were drawn to isolate GFP+ mCherry-cells (indicating successful HDR) and mCherry+ GFP- ells (indicating imprecise repair) for mock-transfected sample (C) and treated sample (D). G, H. K562 GFP+ cells were gated for BFP+ events (precise) and double-negative events (imprecise). Representative mock-transfected (G) and treated (H) samples are shown.</p></caption><graphic xlink:href="354480v2_figs9" position="float" orientation="portrait" hwp:id="graphic-15"/></fig></sec><sec id="s4" hwp:id="sec-13"><title hwp:id="title-18">Materials and Methods</title><sec id="s4a" hwp:id="sec-14"><title hwp:id="title-19">Synthesis of PNA-NLS peptide</title><p hwp:id="p-50">PNA oligomers were synthesized at 2µmol scale on Fmoc-PAL-PEG-PS solid support (Applied Biosystems) using an Expedite 8909 synthesizer. Fmoc/Bhoc-protected PNA monomers (Link Technologies) were dissolved to 0.2M in anhydrous <italic toggle="yes">N</italic>-methylpyrrolidinone. Amino acid monomers (Sigma Aldrich) and AEEA linker (Link Technologies) were dissolved to 0.2 M in anhydrous dimethylformamide. Coupling time was 8.5 min using HATU (Alfa Aesar) as activator; double coupling was performed on all PNA monomers and amino acids. PNAs were cleaved and deprotected by treating the resin with 400 µL of 19:1 TFA:<italic toggle="yes">m</italic>-Cresol for 90 min at room temperature. The resin was then removed with a PTFE centrifugal filter and PNAs were precipitated from cold diethyl ether and resuspended in deionized water. PNAs were purified by HPLC on a Waters XSelect CSH C18 5µm column at 60 °C, using gradients of acetonitrile in water containing 0.1% TFA, and were characterized on an Agilent 6530 Q-TOF LC/MS system with electrospray ionization. The PNA::NLS sequence used was GCGCTCGGCCCTTCC-[AEEA linker]-PKKKRK.</p></sec><sec id="s4b" hwp:id="sec-15"><title hwp:id="title-20">Synthesis of PEGylated oligos</title><p hwp:id="p-51">PEG-modified oligonucleotides were synthesized using standard phosphoramidite methods on an ABI 394 synthesizer. Phosphoramidites were purchased from ChemGenes. Coupling times for 2′OMe-RNA and spacer phosphoramidites were extended to 5 min. Oligonucleotides were deprotected in concentrated aqueous ammonia at 55 °C for 16 h. Oligonucleotides were desalted using either Nap-10 (Sephadex) columns or Amicon ultrafiltration. All the PEG-modified oligonucleotides were characterized on an Agilent 6530 Q-TOF LC/MS system with electrospray ionization. The 2′-OMe RNA sequence appended to the 5′-end of donor DNAs was GGAAGGGCCGAGCGC.</p></sec><sec id="s4c" hwp:id="sec-16"><title hwp:id="title-21">dsDNA Donor generation</title><p hwp:id="p-52">Donor template sequences with the homology arms and the desired insert for knock-in (eg: gfp), were generated by PCR. PCR products were cloned into ZeroBlunt TOPO vector (Invitrogen, #450245) and plasmids were purified using Macherey-Nagel midi-prep kits (cat# 740412.50). Using the purified plasmids as templates and PEGylated oligos as primers, donor sequences were PCR amplified with Q5 (NEB, <italic toggle="yes">C. elegans</italic>) or Q5 or Phusion polymerase (NEB, mammalian). Before use in <italic toggle="yes">C. elegans</italic> microinjections, the resulting PEGylated PCR products were excised from 0.8-1% TAE agarose gel and purified using spin-columns (Omega, #D2501-02). For use in mammalian cells, the PEGylated long PCR products were purified using spin columns (Qiagen, # 28104) and short PCR products were gel-extracted (Omega, #D2501-02) and then purified again with Ampure XP beads.</p></sec><sec id="s4d" hwp:id="sec-17"><title hwp:id="title-22">Single Strand DNA donor generation</title><p hwp:id="p-53">Long single stranded DNA donors were prepared using the protocol described by Li et al <sup><xref ref-type="bibr" rid="sc1" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">1</xref></sup>. Briefly, the donor template containing the T7 promoter was amplified using standard PCR and purified using SPRI magnetic beads (Core Genomics). T7 <italic toggle="yes">in vitro</italic> transcription was performed using the HiScribe T7 High Yield RNA Synthesis kit (NEB) and the RNA was purified using the SPRI magnetic beads. Finally, the ssDNA donor was synthesized by TGIRT™-III (InGex) based reverse transcription using the synthesized RNA as a template and a TEG-modified or unmodified DNA primer. We then performed base-treatment to remove RNA. The donor was again purified using SPRI beads.</p></sec><sec id="s4e" hwp:id="sec-18"><title hwp:id="title-23">Expression and purification of SpyCas9</title><p hwp:id="p-54">The pMCSG7 vector containing the 6xHis-tagged 3xNLS SpyCas9 was a gift from Scot Wolfe at UMass Medical School. This construct was transformed into the Rosetta 2 DE3 strain of <italic toggle="yes">E. coli</italic> for protein production. Expression and purification of SpyCas9 was performed as described previously <sup><xref ref-type="bibr" rid="sc2" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">2</xref></sup>. Briefly, cells were grown at 37°C to OD600 of 0.6, at which point 1 mM IPTG (Sigma) was added and the temperature was lowered to 18°C. Cells were grown overnight and harvested by centrifugation at 4,000 g. The protein was purified first by Ni<sup>2+</sup> affinity chromatography, then by cation exchange and finally by size-exclusion chromatography.</p></sec><sec id="s4f" hwp:id="sec-19"><title hwp:id="title-24">Illumina sequencing (Mammalian cells)</title><p hwp:id="p-55">Regions of interest were amplified from genomic DNA and sequenced on an Illumina MiniSeq platform. PCR1 ((98° C-2min, 24 cycles of (98° C-15sec, 64° C-20sec, 72° C-15sec), 72° C-5min) was performed using 200ng gDNA, 1.25uL of 10uM forward and reverse primers that contain Illumina adapter sequences, 12.5uL NEBNext UltraII Q5 Master Mix, and water to bring the total volume to 25uL. PCR2 (98° C-2min, 10 cycles of (98° C-15sec, 64° C-20sec, 72° C-15sec), 72° C-5min) was done using 1uL of unpurified PCR1 reaction mixture, 1.25 uL of 10uM forward and reverse primers that contain unique barcode sequences, 12.5uL NEBNext UltraII Q5 Master Mix, and water to bring the total volume to 25uL. PCR2 products were first analyzed using 2% agarose gel electrophoresis, and then similar amounts were pooled based on the band intensities. Pooled PCR2 products were first purified by gel extraction (Qiagen) and purified again by PCR cleanup columns (Qiagen). Concentration of final purified library was determined by Qubit (High Sensitivity DNA assay). The integrity of library was confirmed by Agilent Tapestation using Agilent High Sensitivity D1000 ScreenTape kit. The library was then sequenced on an Illumina Miniseq platform according to the manufacturer’s instructions using MiniSeq Mid Output Kit (300-cycles). Sequencing reads were demultiplexed using bcl2fastq2 (Illumina) and CRISPResso2 <sup><xref ref-type="bibr" rid="sc3" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">3</xref></sup> was used to align the reads and quantify editing efficiencies. Quantification window size was set as 30 to ensure the stringent analysis. HDR efficiency was calculated as percentage of (precise HDR reads) / (total reads).</p></sec><sec id="s4g" hwp:id="sec-20"><title hwp:id="title-25">Guide-Seq Experiment</title><p hwp:id="p-56">Two phosphorothioate linkages were incorporated between the first three and the last three nucleotides in the dsODN tags. Unmodified dsODN does not contain any further modifications whereas modified dsODN contains 5′ TEG (SP9) modification (Integrated DNA Technologies). Sequencing libraries were prepared as previously described <sup><xref ref-type="bibr" rid="sc4" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">4</xref></sup>. Data was processed and analyzed using the GUIDE-seq analysis software <sup><xref ref-type="bibr" rid="sc4" hwp:id="xref-ref-48-2" hwp:rel-id="ref-48">4</xref></sup>.</p></sec><sec id="s4h" hwp:id="sec-21"><title hwp:id="title-26">Cell culture and transfections</title><p hwp:id="p-57">HEK293T cells were obtained from ATCC and were cultured in standard DMEM medium (Gibco, #11995) supplemented with 10% fetal bovine serum (FBS) (Sigma, #F0392). Human foreskin fibroblasts (HFF) were maintained in DMEM medium supplemented with 20% FBS. Chinese hamster ovary (CHO) cells (obtained from ATCC) were cultured in F-12K medium (Gibco 21127022) supplemented with 10% FBS, and K562 cells were cultured in IMDM medium (Gibco 12440053) supplemented with 10% FBS. Traffic Light Reporter Multi-Cas Variant 1 (TLR-MCV1) reporter cells were previously described <sup><xref ref-type="bibr" rid="sc5" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">5</xref></sup>. Electroporations were performed using the Neon transfection system (ThermoFisher). SpyCas9 was delivered either as a plasmid or as protein. For plasmid delivery of Cas9 and sgRNA, appropriate amounts of plasmids were mixed in ∼10 µl Neon buffer-R (ThermoFisher) followed by the addition of 100,000 cells. For RNP delivery of Cas9 (IDT), GFP-to-BFP assay (20 pmolCas9 and 25 pmol of crRNA-tracrRNA), EMX1-HEK293T (5pmol Cas9, 10pmol sgRNA (IDT)), EMX1-K562 (10pmol Cas9, 20pmol sgRNA), were mixed in 10 µl of buffer R. This mixture was incubated at room temperature for 30 minutes followed by the addition of 100,000 cells that were already resuspended in buffer R. This mixture was then electroporated using the 10µl Neon tips. Electroporation parameters (pulse voltage, pulse width, number of pulses) were 1150 v, 20 ms, 2 pulses for HEK293T cells, 1650 v, 10 ms, 3 pulses for CHO cells, 1400 v, 30 ms, 1 pulse for HFF cells and 1600 v, 10 ms, 3 pulses for K562 cells. Electroporated cells were harvested for FACS analysis 48-72 hr post electroporation unless mentioned otherwise.</p></sec><sec id="s4i" hwp:id="sec-22"><title hwp:id="title-27">K562 GFP+ stable cell line generation</title><p hwp:id="p-58">Lentiviral vector expressing EGFP was cloned using the Addgene plasmid #31482. The EGFP sequence was cloned downstream of the SFFV promoter using Gibson assembly. For lentivirus production, the lentiviral vector was co-transfected into HEK293T cells along with the packaging plasmids (Addgene 12260 &amp; 12259) in 6-well plates using TransIT-LT1 transfection reagent (Mirus Bio) as recommended by the manufacturer. After 24 hours, the medium was aspirated from the transfected cells and replaced with fresh 1 ml of fresh DMEM media. The next day, the supernatant containing the virus from the transfected cells was collected and filtered through a 0.45 µm filter. 10 µl of the undiluted supernatant along with 2.5µg of Polybrene was used to transduce ∼1 million K562 cells in 6-well plates. The transduced cells were selected using media containing 2.5 µg/ml of puromycin. Less than 20% of the transduced cells survived, and these were then diluted into 96-well plates to select single clones. One of the K562 GFP+ clones was used for the analysis shown in this study. Cas9 was electroporated into the K562 GFP+ cells as RNP (20 pmol) with a crRNA targeting the <italic toggle="yes">GFP</italic> sequence. ssODN (66 nt) with or without end modifications was provided as donor template to convert the <italic toggle="yes">GFP</italic> coding sequence to the <italic toggle="yes">BFP</italic> coding sequence. % BFP (+) (HDR) and % GFP (-) BFP (-) (NHEJ) cells were quantified using flow cytometry.</p></sec><sec id="s4j" hwp:id="sec-23"><title hwp:id="title-28">Flow cytometry</title><p hwp:id="p-59">The electroporated cells were analyzed on a MACSQuant VYB from Miltenyi Biotec. Cells were gated first based on forward and side scattering to select “live” cells and then for single cells. GFP-positive cells were identified using the blue laser (488 nm) and 525/50 nm filter whereas for the detection of mCherry positive cells, yellow laser (561 nm) and 615/20 nm filter were used. BFP-positive cells were identified using the violet laser (405 nm) and 450±50 nm filter. The gating strategy is shown in <bold><xref ref-type="fig" rid="figs9" hwp:id="xref-fig-15-1" hwp:rel-id="F15">Figure S9</xref></bold>.</p></sec><sec id="s4k" hwp:id="sec-24"><title hwp:id="title-29">Southern Blotting to visualize donor concatemers</title><p hwp:id="p-60">dsDNA donors (566bp) were prepared using DIG labeled dUTP nucleotide mix ((Sigma Aldrich # 11585550910). 1.5 pmol of gel-extracted DNA was nucleofected into HEK293T (100,000) cells (Cas9 or guideRNAs were not added to the mix). Nucleofected cells were collected at various time points and pellets were frozen at −80° C until processed for DNA extraction. Total DNA was extracted using buffered Phenol: Chloroform: Isoamyl Alcohol and quantified using Qubit (HS-DNA). Total DNA (genomic + exogenous) of 200ng (0 hr to 24 hr) or about 800ng (48 hr and 72 hr) was used for agarose gel (0.8%) electrophoresis. Higher amounts of DNA were loaded for the later time points to blot for roughly equal amounts of exogenous DNA and to account for the increase in total cell number over the time course. 200pg of 566bp and 800pg of 13kb DIG labelled PCR DNA were used as size markers. After electrophoresis agarose gel was treated with 0.25N HCl (depurination) for 10 min followed by three washes with distilled water. The gel was then treated with denaturing solution (0.5M NaOH and 1.5M NaCl) for 20 min and another 30 min with fresh solution; followed by neutralization (2 washes 10 minutes each) with Alkaline transfer buffer (5xSSC with 10mM NaOH). Using Alkaline transfer buffer, DNA was then transferred for 3 hours with upward capillary action onto positively charged nylon membrane (Amersham Hybond N+, RPN303B). After transfer, membrane was soaked in 5xSSC for 10 min and UV crosslinked. Blots were then processed using DIG Wash and Block buffer set (Sigma Aldrich # 11585762001) according to the manufacturer’s protocol. Briefly, membrane was blocked in 1x blocking solution with Maleic acid for 30 min, incubated with 1:20,000 Anti-Digoxigenin-AP, Fab fragments (Sigma Aldrich # 11093274910) in 1x blocking solution for 1 hour, washed twice with 1x wash buffer, incubated in 1x detection buffer and developed using CDP-star (Sigma Aldrich # 12041677001).</p></sec><sec id="s4k1" hwp:id="sec-25"><title hwp:id="title-30"><italic toggle="yes">C. elegans</italic> microinjection and HDR screening</title><p hwp:id="p-61">Microinjections were performed using Cas9-RNPs as previously described <sup><xref ref-type="bibr" rid="sc6" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">6</xref></sup>. dsDNA donors were generated by PCR; 25ng/µl of unmodified or end-modified dsDNA donors were used in each injection mixture. Donors were heated and quick-cooled as previously described <sup><xref ref-type="bibr" rid="sc6" hwp:id="xref-ref-50-2" hwp:rel-id="ref-50">6</xref></sup>. Starting strain that is homozygous for 3XFLAG::GlyGlyGly::TEV::CSR-1 allele was used to knock-in <italic toggle="yes">gfp</italic> sequence between flag and glycine-linker. crRNA (CTATAAAGACGATGACGATA NGG) with PAM site in the glycine-linker and donor DNA with arms homologous to 35 bp of 3xflag and 30 bp of 3xglycine-linker::tev flanking the gfp sequence were used. Loss of function WM702 (<italic toggle="yes">eft3p::gfp(ne4807))</italic> reporter strain was generated in EG6070 (oxSi221 [eft-3p::GFP + Cbr-unc-119(+)] II) strain background using CMG-48 and CMG-49 guides (See Supplemental Table S1). <italic toggle="yes">Rol-6 (su1006)</italic> plasmid was used as co-injection marker. This marker plasmid forms episomal non-integrating extrachromosomal elements that transiently mark a subset of progeny by causing them to exhibit an easily scored Roller phenotype. Under the conditions used, high quality injections into both gonad arms yielded 20 to 40 Roller progenies from each injected animal. For each donor type entire F1 broods from four or more injected animals were scored and tabulated the total number of GFP positive progeny and the number of GFP positive Roller progeny.</p></sec><sec id="s4l" hwp:id="sec-26"><title hwp:id="title-31">Zebrafish Experiments</title><sec id="s4l1" hwp:id="sec-27"><title hwp:id="title-32">Fish Care</title><p hwp:id="p-62">Fish were maintained in accordance with the protocols set by the University of Massachusetts Medical School Institutional Animal Care and Use Committee. All the injections were performed into embryos derived from in-crosses of the EK wildtype line.</p></sec><sec id="s4l2" hwp:id="sec-28"><title hwp:id="title-33">Zebrafish zygote microinjections</title><p hwp:id="p-63">One cell-staged embryos were injected with 30pg of either unmodified or end-modified donors together with 24fmol RNP of modified Cas12a protein (Lb-2C-Cas12a) and modified crRNA (dr crRNA) per embryo as described previously <sup><xref ref-type="bibr" rid="sc7" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">7</xref></sup>, targeting 5′ end of the <italic toggle="yes">hey2</italic> coding sequence. Embryos were incubated for 24 hours post injection, genomic DNA was extracted and libraries for amplicon sequencing were prepared. For library construction, linear amplification using a single primer containing UMI was performed first, followed by PCRs for exponential amplification and barcode stitching were performed as described previously <sup><xref ref-type="bibr" rid="sc7" hwp:id="xref-ref-51-2" hwp:rel-id="ref-51">7</xref></sup>. Quantification of the reads containing indels and precise knock-ins of Avi-tag was performed using the Python script deposited at the Github repository: (<ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/locusliu/PCR_Amplicon_target_deep_seq/blob/master/CRESA-lpp.py" ext-link-type="uri" xlink:href="https://github.com/locusliu/PCR_Amplicon_target_deep_seq/blob/master/CRESA-lpp.py" hwp:id="ext-link-2">https://github.com/locusliu/PCR_Amplicon_target_deep_seq/blob/master/CRESA-lpp.py</ext-link>). All the experiments were performed in three independent replicates except injections with unmodified donors which were performed in duplicates.</p></sec></sec><sec id="s4m" hwp:id="sec-29"><title hwp:id="title-34">Mouse Experiments</title><sec id="s4m1" hwp:id="sec-30"><title hwp:id="title-35">Strains and microinjection</title><p hwp:id="p-64">All the mouse experiments were conducted according the UMMS Institute Animal Care and Use Committee (IACUC). C57BL/6J (Stock #000664) and Swiss Webster (Stock #SW) were obtained from Jackson Laboratory and Taconic respectively. All the animals were maintained in a 12 hr light/dark cycle. Superovulated females were mated, and their zygotes were collected at E0.5. Male pronuclei were injected with the injection mixtures described below. Finally, zygotes were transferred to pseudo pregnant recipients and allowed to go to term.</p></sec><sec id="s4m1a" hwp:id="sec-31"><title hwp:id="title-36">Donor preparation</title><p hwp:id="p-65">Using plasmids as templates and either unmodified or end-modified oligos as primers, donor sequences were PCR amplified with Q5 polymerase (NEB). The resulting PCR products were excised from 0.8% TAE agarose gel and purified using spin-columns (Omega, #D2500). Gel-extracted DNA was further purified with 1.5X AMPure XP (Beckman Coulter) beads according to the manufacture’s protocol and eluted in nuclease free water. Before use in microinjection mixes, dsDNA donors were subjected to heating and cooling protocol in thermal cycler as described previously <sup><xref ref-type="bibr" rid="sc6" hwp:id="xref-ref-50-3" hwp:rel-id="ref-50">6</xref></sup>.</p></sec><sec id="s4m2" hwp:id="sec-32"><title hwp:id="title-37">Injection Mixture preparation</title><p hwp:id="p-66">Injections mixes were prepared with the following final concentrations: S.p. Cas9 Protein (50 ng/µl) (IDT); S.p. Cas9 mRNA (50 ng/µl) (TriLink; L-7206); sgRNA (20 ng/µl) (IDT); dsDNA donor (1 ng/µl). Cas9 protein, sgRNA and TE (pH 7.5) were incubated at 37° C for 20 min. This mixture was then equally split into two tubes and the following components were added to each tube: Cas9 mRNA, dsDNA donor (either unmodified or 5′ 2′OMe-RNA::TEG modified), TE (pH 7.5) to bring the total volume to 50 µl. After pipetting well, the final injection mixtures were centrifuged at 14,000g for 2 min and 46 µl was taken from the top (to avoid particles that may clog the needles) and transferred to fresh tubes. All the steps were performed at room temperature. Mixtures were kept on ice and directly loaded into the needles for microinjection.</p></sec><sec id="s4m3" hwp:id="sec-33"><title hwp:id="title-38">Genotyping</title><p hwp:id="p-67">Tail clips of <italic toggle="yes">Sox2-V5</italic> founder animals were collected at P10, genotyped by PCR and Sanger sequenced to confirm precise insertion. To confirm germline transmission, some of the HDR positive F0 animals were mated with WT animals and tail clips of F1 animals were genotyped.</p></sec></sec><sec id="s4n" hwp:id="sec-34"><title hwp:id="title-39">Oligo Sequences</title><p hwp:id="p-68">Sequences of all the guide RNAs used in this study are provided in Supplemental Table S1 and sequences of all the oligos used are provided in Supplemental Table S2.</p></sec><sec id="s4o" hwp:id="sec-35"><title hwp:id="title-40">Statistics</title><p hwp:id="p-69">All the statistical analyses were performed using GraphPad Prism. The type of analysis performed, and the P-value information can be found in respective figure legends.</p></sec><sec id="s4p" hwp:id="sec-36"><title hwp:id="title-41">Data availability</title><p hwp:id="p-70">All the data supporting the findings of this study are available within the paper and supplementary information. Any other data related to this manuscript are available upon reasonable request.</p></sec></sec></sec><ref-list hwp:id="ref-list-2"><title hwp:id="title-42">References</title><ref id="sc1" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-46">Design and specificity of long ssDNA donors for CRISPR-based knock-in</article-title>. <source hwp:id="source-45">bioRxiv</source>, <volume>178905</volume>, doi:<pub-id pub-id-type="doi">10.1101/178905</pub-id> (<year>2019</year>).</citation></ref><ref id="sc2" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Jinek M."><surname>Jinek</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-47">A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity</article-title>. <source hwp:id="source-46">Science</source> <volume>337</volume>, <fpage>816</fpage>–<lpage>821</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1225829</pub-id> (<year>2012</year>).</citation></ref><ref id="sc3" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Clement K."><surname>Clement</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-48">CRISPResso2 provides accurate and rapid genome editing sequence analysis</article-title>. <source hwp:id="source-47">Nat Biotechnol</source> <volume>37</volume>, <fpage>224</fpage>–<lpage>226</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41587-019-0032-3</pub-id> (<year>2019</year>).</citation></ref><ref id="sc4" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1 xref-ref-48-2"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Tsai S. Q."><surname>Tsai</surname>, <given-names>S. Q.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-49">GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases</article-title>. <source hwp:id="source-48">Nat Biotechnol</source> <volume>33</volume>, <fpage>187</fpage>–<lpage>197</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nbt.3117</pub-id> (<year>2015</year>).</citation></ref><ref id="sc5" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Iyer S."><surname>Iyer</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-50">Efficient Homology-directed Repair with Circular ssDNA Donors</article-title>. <source hwp:id="source-49">bioRxiv</source>, <volume>864199</volume>, doi:<pub-id pub-id-type="doi">10.1101/864199</pub-id> (<year>2019</year>).</citation></ref><ref id="sc6" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1 xref-ref-50-2 xref-ref-50-3"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Ghanta K. S."><surname>Ghanta</surname>, <given-names>K. S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mello C. C"><surname>Mello</surname>, <given-names>C. C</given-names></string-name>. <article-title hwp:id="article-title-51">Melting dsDNA Donor Molecules Greatly Improves Precision Genome Editing in Caenorhabditis elegans</article-title>. <source hwp:id="source-50">Genetics</source> <volume>216</volume>, <fpage>643</fpage>–<lpage>650</lpage>, doi:<pub-id pub-id-type="doi">10.1534/genetics.120.303564</pub-id> (<year>2020</year>).</citation></ref><ref id="sc7" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1 xref-ref-51-2"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="354480v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Liu P."><surname>Liu</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-52">Enhanced Cas12a editing in mammalian cells and zebrafish</article-title>. <source hwp:id="source-51">Nucleic Acids Res</source> <volume>47</volume>, <fpage>4169</fpage>–<lpage>4180</lpage>, doi:<pub-id pub-id-type="doi">10.1093/nar/gkz184</pub-id> (<year>2019</year>).</citation></ref></ref-list></back></article>
